Trial intelligence / Profile preview

Atomoxetine Pilot Study in Preschool Children With ADHD

NCT00517647Phase 4Completed

Sponsor
University of Arizona
Start
Apr 2004
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by University of Arizona. Started Apr 2004; status: completed.

02

Drugs

atomoxetine
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00517647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00517647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call